Non-Invasive RF Glucose Monitoring via Machine Learning Waveform Matching

The patent replaces the mechanical invasive blood sampling system with a non-invasive optical detection system. The system uses light absorption spectroscopy to measure glucose levels through blood flow in the tissue, eliminating needles and invasive procedures while maintaining continuous monitoring capability. This substitution resolves the contradiction by removing the harmful invasive element while preserving measurement functionality.

The patent introduces an optical intermediary (light) to mediate between the glucose molecules and the detector. Instead of directly extracting and analyzing blood samples, the system uses light absorption characteristics of glucose-containing blood flow to indirectly measure glucose levels. This intermediary approach enables non-invasive measurement, resolving the contradiction between accuracy and patient safety.

The patent implements continuous optical monitoring of glucose levels by continuously detecting light absorption changes in blood flow. Unlike discrete blood sampling, the system maintains uninterrupted measurement by continuously analyzing the optical properties of flowing blood through the tissue, ensuring both real-time monitoring and consistent data reliability without gaps.

The system performs preliminary calibration and baseline establishment before surgical procedures begin, creating reference profiles for each patient. This preliminary action enables the system to accurately interpret real-time optical signals during surgery, improving both the speed and reliability of glucose monitoring by having pre-established reference data for comparison.

The patent applies local quality by selecting specific wavelengths of light that are optimally absorbed by glucose molecules while minimizing interference from other tissue components. The system uses multiple discrete wavelengths, each optimized for detecting specific glucose-related optical signatures, thereby achieving precise measurements through non-invasive means by tailoring the optical properties to the specific measurement goal.

The system implements feedback mechanisms by continuously comparing real-time optical signals against reference profiles and using algorithms to compensate for variations in tissue properties, blood flow rates, and environmental factors. This feedback loop maintains measurement precision despite the non-invasive approach by dynamically adjusting for interfering signals and validating readings against established baselines.